Advertisement
Target populations for early diagnosis, disease course prediction and interventions in Alzheimer’s disease are a major focus of current research. Subjective cognitive decline (SCD) has emerged as a pre-mild cognitive impairment (pre-MCI) at risk condition of dementia and cognitive decline.
Read our new thematic series, guest edited by José Luis Molinuevo, Frank Jessen & Wiesje Van der Flier
Alzheimer's Research & Therapy is the major forum for translational research into Alzheimer's disease. An international peer-reviewed journal, it publishes open access basic research with a translational focus, as well as clinical trials, research into drug discovery and development, and epidemiologic studies. The journal also provides reviews, viewpoints, commentaries, debates and reports.
Although the primary focus is Alzheimer's disease, the scope encompasses translational research into other neurodegenerative diseases.
Wikimedia Commons
Brain resilience is the process of adapting well in the face of significant sources of stress, such as Alzheimer’s disease pathology, other neurodegenerative conditions or biological aging. This thematic series provides a comprehensive overview of what factors contribute to brain resilience and how this affects brain health and cognitive function.
Guest Editor: Rik Ossenkoppele
Publication: Ongoing but closed for submissions
Advertisement
Alzheimer's Research & Therapy is affiliated with Alzheimer's Disease International (ADI), London, United Kingdom.
Speed
55 days to first decision for reviewed manuscripts only
40 days to first decision for all manuscripts
133 days from submission to acceptance
31 days from acceptance to publication
Citation Impact
6.142 - 2-year Impact Factor
7.072 - 5-year Impact Factor
1.601 - Source Normalized Impact per Paper (SNIP)
2.404 - SCImago Journal Rank (SJR)
Usage
522,695 downloads
937 Altmetric mentions
Advertisement
Alzheimer's Research & Therapy
